Jubilant Pharmova Ltd Share Price (JUBLPHARMA)
₹681.1▲2.42%
Jubilant Pharmova Ltd share Performance
- ₹672.75₹695.2₹681.1
1.23%
Low
Day's Volatility:3.30%
High
2.07%
- ₹299.05₹724.4₹681.1
56.09%
Low
52 Weeks Volatility:62.45%
High
6.36%
| Returns % | |
| 1 Month Return | 17.73 % |
| 3 Month Return | 24.24 % |
| 1 Year Return | 118.35 % |
| Market Stats | |
| Previous Close | ₹665.00 |
| Open | ₹676.85 |
| Volume | 5.90L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹10,593.45Cr |
Company Information
Share Price: ₹681.10 per share as on 22 Apr, 2024 04:01 PM
Market Capitalisation: ₹10,593.45Cr as of today
Revenue: ₹1,665.20Cr as on December 2023 (Q4 23)
Net Profit: ₹66.40Cr as on December 2023 (Q4 23)
Listing date: 09 Nov, 1994
Chairperson Name: Shyam S Bhartia
| Organisation | Jubilant Pharmova Ltd |
| Headquarters | Noida |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Jubilant Pharmova Ltd
Jubilant Pharmova Receives VAI Status for Roorkee Plant; Closes Down Maryland Facility Due to Losses - 18 Apr, 2024
Jubilant Pharmova's subsidiary received a VAI status for its Roorkee plant while Jubilant Cadista decided to close its Maryland facility due to mounting losses. The company plans to move towards profitability through outsourced manufacturing. Shares surged up to 8% on April 18.
USFDA Classifies Jubilant Pharma Plant as VAI - 17 Apr, 2024
Jubilant Pharmova's subsidiary, Jubilant Generics, received a VAI classification from the USFDA for its Roorkee-based manufacturing facility. The FDA has concluded that this inspection is closed.
Private Companies Bet Big on Jubilant Pharmova - 10 Apr, 2024
Jubilant Pharmova's top 4 shareholders, including private companies, own 54% of the company. Institutional investors and hedge funds also have a fair amount of stake in the company. The stock gained 10% last week.
Jubilant Pharmova Records Surge in Volume and Stock Price - 04 Apr, 2024
Jubilant Pharmova Ltd's stock price surged by 9.06% to Rs.631.90 as the company recorded a 15.23 times surge in trading volume with 32.62 lakh shares traded on NSE.
Jubilant Pharmova Receives Tax Demand - 02 Apr, 2024
Jubilant Pharmova has received a tax demand of Rs 228.75 crore from the Income Tax Department, primarily due to arithmetical errors and disallowances. The company expects relief from relevant authorities.
Jubilant Pharmova Appoints Two Additional Directors - 26 Mar, 2024
Jubilant Pharmova's board has approved the appointment of Dr. Harsh Mahajan and Shivpriya Nanda as additional directors (non-executive, independent) effective April 1, 2024.
Fundamentals of Jubilant Pharmova Ltd
Insights on Jubilant Pharmova Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 1.59K Cr → 1.72K Cr (in ₹), with an average increase of 3.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 4 quarters, -97.9 Cr → 66.8 Cr (in ₹), with an average increase of 575.3% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 25.56% to 25.90% in Mar 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, JUBLPHARMA stock has moved up by 85.5%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 1.50% to 2.27% in Mar 2024 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, JUBLPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 138.0% return, outperforming this stock by 156.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.68% of holdings in Mar 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 20.29% to 19.06% in Mar 2024 quarter
Jubilant Pharmova Ltd Valuation
Jubilant Pharmova Ltd in the last 5 years
Lowest (-195.50x)
December 29, 2023
Industry (61.04x)
April 19, 2024
Today (275.93x)
April 19, 2024
Highest (290.75x)
April 18, 2024
Mutual Fund Holdings
| Funds | Holdings |
 Quant Flexi Cap Fund Growth Option Direct Plan | 1.81% |
| Quant Small Cap Fund Growth Option Direct Plan | 0.33% |
 Nippon India Pharma Fund - Direct Plan - Growth Plan | 0.38% |
| Quant Healthcare Fund Direct Growth | 5.39% |
 HDFC Pharma and Healthcare Fund Direct Growth | 1.39% |
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.68% | 0.00 | |
| Foreign Institutions | 19.06% | 0.00 | |
| Mutual Funds | 2.27% | 0.00 | |
| Retail Investors | 25.9% | 0.00 | |
| Others | 2.09% | 0.00 |
Technicals of Jubilant Pharmova Ltd share
News & Events of Jubilant Pharmova Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Jubilant Pharmova Ltd shares.
Jubilant Pharmova Ltd (JUBLPHARMA) share price today is ₹681.1
Jubilant Pharmova Ltd is listed on NSE
Jubilant Pharmova Ltd is listed on BSE
- Today’s highest price of Jubilant Pharmova Ltd is ₹695.2.
- Today’s lowest price of Jubilant Pharmova Ltd is ₹672.75.
PE Ratio of Jubilant Pharmova Ltd is 275.93
PE ratio = Jubilant Pharmova Ltd Market price per share / Jubilant Pharmova Ltd Earnings per share
Today’s traded volume of Jubilant Pharmova Ltd(JUBLPHARMA) is 5.90L.
Today’s market capitalisation of Jubilant Pharmova Ltd(JUBLPHARMA) is ₹10593.45Cr.
| Jubilant Pharmova Ltd(JUBLPHARMA | Price |
|---|---|
52 Week High | ₹724.4 |
52 Week Low | ₹299.05 |
Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹681.1. It is down -5.98% from its 52 Week High price of ₹724.4
Jubilant Pharmova Ltd(JUBLPHARMA) share price is ₹681.1. It is up 127.75% from its 52 Week Low price of ₹299.05
| Jubilant Pharmova Ltd(JUBLPHARMA | Returns |
|---|---|
1 Day Returns | 16.1% |
1 Month Returns | 17.73% |
3 Month Returns | 24.24% |
1 Year Returns | 118.35% |